Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Today in Healthcare.
Press releases published on July 1, 2025
Lixte Biotechnology Holdings, Inc. Announces $5.0 Million Private Placement Priced at the Market
GlobeNewswire
·
July 1, 2025
PASADENA, CALIF, July 01, 2025 (GLOBE NEWSWIRE) -- Lixte Biotechnology Holdings, Inc. (NASDAQ: LIXT) (the “Company”), a clinical stage pharmaceutical company, today announced that, on June 30, 2025 intraday, it entered into a definitive agreement with …
In-Situ Hybridization Market Report 2025 – For Strategy Officers And Market Intelligence Teams
EIN Presswire
·
July 1, 2025
The Business Research Company's In-Situ Hybridization Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, July 1, 2025 /EINPresswire.com/ -- Save 30% On All Global Market Reports With …
Protara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
July 1, 2025
NEW YORK, July 01, 2025 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA) (“Protara” or the “Company”), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced the recent …
Abacus Global Management Sues Coventry and its Chairman Alan Buerger for Defamation and Anticompetitive Conduct
GlobeNewswire
·
July 1, 2025
Coventry and Chairman Alan Buerger Engaged in Years-Long Campaign to Systematically Disseminate False and Misleading Information About the Publicly-Traded Company Coventry and Buerger Found a Key Partner and Megaphone for its Defamatory Statements: Short …
Resmed to Report Fourth Quarter Fiscal 2025 Earnings on July 31, 2025
GlobeNewswire
·
July 1, 2025
SAN DIEGO, July 01, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the fourth quarter of fiscal year 2025 on Thursday, July 31, 2025, after the New York Stock Exchange closes. …
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
July 1, 2025
CAMBRIDGE, Mass., July 01, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, granted four newly-hired employees options to purchase an …
ArriVent Announces Proposed $75 Million Public Offering of Common Stock and Pre-Funded Warrants
GlobeNewswire
·
July 1, 2025
NEWTOWN SQUARE, Pa., July 01, 2025 (GLOBE NEWSWIRE) -- ArriVent BioPharma, Inc. (“ArriVent”) (Nasdaq: AVBP), a clinical-stage company dedicated to accelerating the global development of innovative biopharmaceutical therapeutics, today announced that it …
Cue Biopharma Provides Update on Most Advanced Clinical Stage Asset, CUE-101, Presented by Dr. Dimitrios Colevas at the DAVA 4th Hawaii Global Summit on Thoracic Malignancies
GlobeNewswire
·
July 1, 2025
ORR of 50% in treatment-naïve patients with HPV+ R/M HNSCC 12-month landmark survival of 88% and mOS of 32 months BOSTON, July 01, 2025 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel …
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
July 1, 2025
CHARLESTOWN, Mass., July 01, 2025 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB) (the “Company”), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, today announced grants of 105,330 restricted …
Venus Concept Announces $6.5 Million Debt-to-Equity Exchange Transaction
GlobeNewswire
·
July 1, 2025
TORONTO, July 01, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that, on June 30, 2025, the Company exchanged $6.5 million of its subordinated …
LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
July 1, 2025
ORLANDO, Fla., July 01, 2025 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”) today announced that a majority of the independent members of LENSAR’s board of directors granted three newly-hired non-executive employees an …
Oruka Therapeutics Announces Promotion of Laura Sandler to Chief Operating Officer
GlobeNewswire
·
July 1, 2025
MENLO PARK, Calif., July 01, 2025 (GLOBE NEWSWIRE) -- Oruka Therapeutics, Inc. (“Oruka”) (Nasdaq: ORKA), a clinical-stage biotechnology company developing novel biologics designed to set a new standard for the treatment of chronic skin diseases including …
KT Cap Consulting announced its partnership with Taiwan based Leo International Group
EIN Presswire
·
July 1, 2025
Singapore based KT Cap Consulting (KTCC) is pleased to announce the signing of a Memorandum of Understanding (MoU) with Leo International Group SINGAPORE, SINGAPORE, SINGAPORE, July 1, 2025 /EINPresswire.com/ -- KT Cap Consulting announced its …
Methinks AI receives FDA 510(k) clearance to expand the frontiers of Non-Contrast CT for stroke triage
EIN Presswire
·
July 1, 2025
It is the first and only LVO detection software capable of detecting LVOs up to the MCA-M2 level using NCCT BARCELONA, SPAIN, July 1, 2025 /EINPresswire.com/ -- While reducing false-negative errors by nearly half according to FDA validation studies. …
A Triumph for Physical Therapists: Hands On Diagnostics Celebrates Historic ECS Board Pass Rate
EIN Presswire
·
July 1, 2025
A New Era of Board-Certified Electrophysiologic Specialists Begins ASTORIA, NY, UNITED STATES, July 1, 2025 /EINPresswire.com/ -- Hands-On Diagnostics (HODS) and the American Academy of Clinical Electrodiagnosis (AACE) are proud to celebrate a momentous …
Vor Bio Report Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
July 1, 2025
CAMBRIDGE, Mass., July 01, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced that, effective as of June 26, 2025, the Board of Directors granted Jean- …
Effective Testosterone Booster for Men Over 50: TestoPrime Medically Accredited as the Best Testosterone Supplement for Males In 40's and 50's
GlobeNewswire
·
July 1, 2025
New York City, NY, July 01, 2025 (GLOBE NEWSWIRE) -- For men in their 40s and 50s seeking a proven, safe, and powerful way to restore youthful energy, muscle, and vitality, a breakthrough solution has arrived. TestoPrime, the most effective testosterone …
SOMAÍ and Lusófona Publish Peer-Reviewed Study Showcasing Best Practices in Full-Spectrum Cannabis Oil Production
EIN Presswire
·
July 1, 2025
LISBON, PORTUGAL, July 1, 2025 /EINPresswire.com/ -- SOMAÍ, a leading EU-GMP-certified vertically integrated Multi-Country Operator (MCO) specializing in cannabinoid-based medicines, in collaboration with Lusófona University, the largest Portuguese …
The German Neuroscience Center Expands Its Operations and Introduces New Treatment Options
EIN Presswire
·
July 1, 2025
TMS Therapy and IV Therapy introduced to treat depression and support brain health DUBAI, DUBAI, UNITED ARAB EMIRATES, July 1, 2025 /EINPresswire.com/ -- The German Neuroscience Center, one of the UAE’s leading psychology, psychiatry, and neurology …
Fred Meyer and Washington State Collaborate to Provide Free Locking Bags to Prevent Opioid Misuse
GlobeNewswire
·
July 1, 2025
Olympia, Washington, July 01, 2025 (GLOBE NEWSWIRE) -- Customers at Fred Meyer’s 60 pharmacies in Washington now have access to free locking bags to more safely store their opioid prescriptions. The Washington State Health Care Authority (HCA) is …